The aim of this study is to pilot FORGET as screening tool for dementia in community OP clinic and acute medical hospital assessments. Sample size included 30 each of memory clinic and acute medical hospital patients. Assessments included FORGET and MMSE. Psychometric test parameters were calculated for FORGET (Cut-off >1 in OP clinic and >3 in acute medical hospital). Of 30 referrals to memory clinic, 25 had dementia. A score >1 on FORGET had sensitivity 80%, specificity 80%, PPV 95.24%, NPV 44.44%, OR 16.00 (p = 0.02) for diagnosis of dementia. Of 30 acute hospital referrals, 20 had dementia. A score >3 on FORGET had sensitivity 95%, specificity 90%, PPV 95% and NPV 90%, OR 171 (p = 0.0005). FORGET at a score of >1 in community and >3 in acute medical hospital is a useful screening tool for dementia.
Introduction
Research conducted for Dementia UK: second edition shows that, in 2013, there were 815,827 people with dementia in the UK [1] . If current trends continue and no action is taken, the number of people with dementia in the UK is forecast to increase to 1,142,677 by 2025 and 2,092,945 by 2051, an increase of 40% over the next 12 years and of 156% over the next 38 years. However, significant "diagnostic gap" for dementia, of more than a 50% exists between predicted prevalence and the actual GP registers across many regions in England, with only 46% of estimated dementia patients having a formal diagnosis locally [2] . This is due to a combination of factors like late patient recognition and presentation to the GPs, delayed referrals from the GPs to specialists and long waiting times to me- mory services. One measure to facilitate early diagnosis of dementia is to have robust and easy to administer screening tools which can be used with reliability at the primary point of contact which is GP surgery and acute medical hospital for elderly individuals.
Conventional screening tests such as Mini-Mental State Examination and 6-CIT (Cognitive Impairment Test) are such tests used in primary and secondary care. They tend to lack focus on history and progression which are crucial evidences for progressive cognitive impairment in dementia. There is also training issue with some if these assessments and they add time towards clinical appointment slots offered in primary care. To overcome these drawbacks, it is important to develop a screening tool for dementia that can be used by health-care providers with ease and confidence.
Method

Analysis of cohorts referred to Basingstoke Older Peoples Mental Health Liaison
Service over 4 months and 102 referrals (data available on request) has showed that duration of cognitive impairment (37.95 weeks vs6.6 weeks) and impaired activities of daily living (ADL; RR 1.73 (95% CI 1.26 -1.37). Hence a screening tool developed to facilitate use by health care professionals in hospital and across community will need to focus on duration of functional impairments and common symptoms of dementia. This has led to development of FORGET (Table 1) .
FORGET consists of 7-items, and takes about 5 -7 minutes to administer. Each item carries a score of 1 leading to maximum score of 7. Although the questions can be answered by carers and patients in early stages of dementia, the tool has been tested on carers. As the items in the screening tools are the most common issues that come up for discussion in clinical assessments, they are easy to capture within the clinic time and the items form the word FORGET, making it easy for clinician to remember. FORGET score offered diagnosis of dementia using ICD-10 criteria. Demographic data including age and gender as well as MMSE score has been collected for all individuals. Sensitivity, specificity, positive predictive value, negative predictive value and odds ratio has been calculated.
Results
Of the 30 patients each assessed in memory clinic and liaison, 25 in memory clinic and 20 in acute medical hospital have received diagnosis of dementia (Table 2 ). Average age of those diagnosed with dementia is memory clinic is 80.64 (68 -92) and in liaison is 86.1 (77 -103). Across both these settings, average age of those with dementia is found to be higher than those without dementia. Women present more with cognitive impairment and hence with dementia, which is common finding in similar studies in dementia. Sub-type of dementia has been made using combination of history, clinical assessment, cognitive as- FORGET score of more than 1 has an odds ratio of 16 (p = 0.02) for diagnosis of dementia in community and has sensitivity of 80% and specificity of 80%.
FORGET score of more than 1 has an odds ratio of 19 (p = 0.06) for diagnosis of and sensitivity becomes 95% as the specificity increases to 90%. PPV, NPV and comparable odds ratios for MMSE are given in Table 3 and Table 4 .
This study also looks at the value of adding MMSE to FORGET as screening.
In community clinic sample MMSE score of less than 27 and FORGET score of more than 1 has a sensitivity of 72% and specificity if 80%. In liaison sample MMSE score of less than 27 and FORGET score of more than 3 has a sensitivity of 95% and specificity if 100%.
Discussion
This pilot study of FORGET as history-based screening tool for dementia demonstrates that in community sample, score of more than 1 provides sensitivity, specificity of 80%, PPV of 95% and NPV of 44%. In acute medical hospital sample, score of more than 3 provides sensitivity of 95%, specificity of 100%, PPV of 95% and NPV of 90%.
Tangalos & Smith et al. [3] report that MMSE cut-off score of 23 or less has a sensitivity of 69% and a specificity of 99 %. In the same study PPV is reported to be less than 35% and that participating physicians consider the MMSE of little value for routine screening in unselected populations. Hessler & Bronner et al. [4] report from their study using 6-CIT that sensitivity and specificity for 6-CIT reaches values of 0.49 and 0.92 at the 7/8 cut-off. They also suggest that the psychometric properties of 6-CIT does not suit itself to be a routine screening tool.
In comparison to these two commonly used screening tests FORGET does have better sensitivity across community and acute hospital samples and better specificity in acute hospital sample. It also matches PPV with a value of 95%.
Thus FORGET does prove to be a useful screening tool in screening for dementia in comparison with the familiar tools of cognitive screening such as MMSE or 6-CIT. Where the real advantage of FORGET is that it is based on history and hence would help the clinician ton have a focused and structured conversation with the patient and carer in understanding symptoms and impact of dementia. Another distinct advantage of FORGET is that it takes much shorter to complete FORGET compared to these tools. It will be time-saving tool for GPs in their surgeries and hospital doctors whilst completing their ward rounds. Another advantage is that unlike MMSE or 6-CIT the test asks for functional impairment and hence will help with formulating care needs for the individual with cognitive impairment.
The advantages of this study include paired FORGET and MMSE scores in community and acute hospital samples and independent assessment by a psychiatrist towards providing ICD-10 based clinical diagnosis blind to FORGET scores. Other advantage includes FORGET achieving sensitivity and specificity measures and better PPV compared to comparable screening tools used in clinical practice. This study also finds that combining FORGET with MMSE can be useful in screening and diagnosing dementia. This study is a pilot and hence incorporated sample size of 30 consecutive assessments in community and liaison. Hence it will need to be replicated using a bigger sample size in acute hospital and community setting. Such bigger studies will have to explore reliability of the tool; however since this is only a structured way of collecting history, and that training is not essential, reliability may not be a problem.
Conclusions
There is an urgent need to make screening processes for dementia easier, less time-consuming and sensitive so that it can be used by healthcare professionals in primary care and acute medical hospitals. This is crucial in early diagnosis of dementia; hence promoting opportunities for an individual with dementia to access appropriate pharmacological and non-pharmacological treatments as well as to make advance directives regarding health and well-being. This pilot study of FORGET an innovative history-based tool for screening dementia in community and acute medical hospital with a cut-off score of more than 1 in the former setting and more than 3 in the latter setting has good sensitivity, specificity as well as positive-predictive value. The values are comparable to cognitive assessment screening tools. In addition FORGET comes with distinct advantages of being easy to administer, less time-consuming and gives clinician perspective on functional impairment from cognitive problem. Hence FORGET can be recommended for routine use in screening for dementia in elderly patients presenting with symptoms of cognitive impairment in primary care and acute medical hospital settings.
